Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Seizure Disorder |
|
|
Clinical Trial: LGBT Internet Based Smoking Treatment - 1
This study is no longer recruiting patients.
Purpose
The overall goals of this line of research are to develop and evaluate innovative treatments for lesbian, gay, bisexual, and transgender (LGBT) cigarette smokers and to understand the processes related to smoking and relapse in this previously unstudied population of smokers. In this study, participants are randomly assigned to one of two Internet-based smoking cessation treatments: 1) a self-help intervention tailored LGBT smokers plus social support plus email-based counseling, or 2) a standard self-help condition alone, similar to other general smoking cessation treatments. Before starting the program, participants will complete measures of smoking, nicotine dependence, depression diagnosis, demographics, mood, motivation to change, and alcohol use. Smoking status will be determined at 1, 3, 6, and 12 months following the start of treatment. Data will be analyzed to compare the quit rates of the two Internet-based treatment groups. Also, we will complete exploratory analyses to determine those variables that best predict quitting for LGBT smokers.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Tobacco Use Disorder | Behavior: Tobacco Use Disorder | Phase III |
MedlinePlus related topics: Smoking
Study Type: Interventional
Study Design: Treatment, Active Control
Official Title: LGBT Internet Based Smoking Treatment
Expected Total Enrollment: 600
Study start: September 2002
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Location Information
California
University of California San Francisco Medical Cen, San Francisco, California, 94143 0939, United States
Gary Humfleet, Ph.D., Principal Investigator, University of California, San Francisco
More Information
Record last reviewed: May 2005
Last Updated: May 20, 2005
Record first received: May 20, 2005
ClinicalTrials.gov Identifier: NCT00111501
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-05-24
email this page
print this page
bookmark this page
feedback on this page
